HRS-1893 - Jiangsu Hengrui Pharma
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Jun 16, 2025 - P2 | N=300 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. 
New P2 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT07021963
 
Jun 16, 2025
 
Prev Next